Electromyography Devices Market Size and Trends

The electromyography (EMG) devices market size is forecast to increase by USD 403.2 million, at a CAGR of 7.1% between 2023 and 2028.  The market is witnessing significant growth due to the increasing prevalence of neuromuscular disorders and the rising use of prostheses. Neuromuscular diseases, such as myasthenia gravis, muscular dystrophies, and amyotrophic lateral sclerosis, are on the rise, leading to a higher demand for EMG devices for diagnosis and treatment. Furthermore, the use of prostheses is increasing, particularly in war-affected countries and developing economies, driving market growth. However, the market faces challenges, including the limitations of EMG devices, such as invasiveness, high cost, and the need for skilled professionals for the operation and interpretation of results. Despite these challenges, the market is expected to grow steadily due to the increasing awareness of neuromuscular disorders and medical technological advancements in EMG devices.

 Request Free Sample

Electromyography (EMG) devices are used in diagnostic tests to assess the health of skeletal muscles and nerves. These devices measure electrical signals produced by muscles during contraction and at rest, providing valuable information about nerve function and muscle health. EMG is a type of electrodiagnostic testing that can identify various conditions affecting the central and peripheral nervous systems, including motor nerves, nerve roots, and peripheral nerves. Common indications for EMG include muscle weakness, numbness, tingling, and other symptoms related to peripheral neuropathy, nerve compression syndromes such as carpal tunnel syndrome, and pinched nerves like cervical radiculopathy and sciatica. EMG can also help diagnose conditions affecting motor neurons, such as post-polio syndrome, myasthenia gravis, and various myopathies, including muscular dystrophy, polymyositis, and dermatomyositis. EMG is often used in conjunction with other diagnostic tests, such as imaging tests and blood tests, to provide a comprehensive evaluation of the patient's condition. EMG is a valuable diagnostic tool for healthcare professionals, enabling accurate diagnosis and effective treatment of various neurological and muscle disorders.

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

• End-user
  • Hospitals and clinics
  • Rehabilitation centers
  • Homecare
• Modality
  • Stationary
  • Portable
• Geography
  • North America
    • US
  • Europe
    • Germany
    • France
  • Asia
  • Rest of World (ROW)

By End-user Insights

The hospitals and clinics segment is estimated to witness significant growth during the forecast period.  Electromyography (EMG) devices are essential diagnostic tools used to assess the electrical activity of skeletal muscles and nerves. This diagnostic test plays a crucial role in identifying various neurological conditions, including muscle weakness, numbness, tingling, peripheral neuropathy, nerve compression syndromes, and motor neuron disorders. The test measures the electrical signals produced by motor nerves and muscles, providing valuable insights into the functioning of the central and peripheral nervous systems.

Get a glance at the market share of various segments Download the PDF Sample

The hospitals and clinics segment was valued at USD 535.20 million in 2018. EMG is particularly helpful in diagnosing conditions such as carpal tunnel syndrome, cervical radiculopathy, sciatica, and pinched nerves. It can also identify nerve root injuries, myopathies, muscular dystrophy, polymyositis, dermatomyositis, post-polio syndrome, and myasthenia gravis. Preparation for the test includes avoiding blood thinner medication and ensuring the skin is clean and dry. During the procedure, a needle electrode is inserted into the muscle to record electrical activity, while a recording device stimulates the muscle to measure muscle contraction. The test duration varies but typically lasts between 30 minutes to an hour, and although it may cause some pain and discomfort, it is generally well-tolerated. EMG results are often complemented with other diagnostic tests, such as imaging tests, blood tests, and muscle biopsies, to provide a comprehensive diagnosis. Electrical medical devices like pacemakers may interfere with EMG results, so patients are advised to inform their healthcare provider about any such devices.

Regional Analysis

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. Electromyography (EMG) is a diagnostic procedure used to assess muscle health and nerve function. During this diagnostic test, electrical activity in muscle and nerve cells is measured to identify symptoms of muscle or nerve disorders, such as weakness, muscle pain, cramping, paralysis, involuntary muscle twitching, radiculopathies, and peripheral nerve disorders. Preparation for an EMG may involve avoiding certain medications, avoiding caffeine, and fasting. Risks of EMG include soreness, bruising, and swelling from needle electrodes, as well as bleeding disorders and allergic reactions. Following the procedure, a follow-up appointment may be necessary to discuss results and consider additional tests or treatments, such as for herniated discs, inflammation, or nerve compression. Symptoms of muscle or nerve disorders may worsen during the procedure, and patients should inform their healthcare provider of any existing conditions, such as heart disease or diabetes, before undergoing EMG.

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Electromyography (EMG) Devices Market Driver

The increasing prevalence of neuromuscular disorders is notably driving market growth. Electromyography (EMG) devices are essential diagnostic tools used to assess the electrical activity of skeletal muscles and nerves. These tests play a crucial role in the diagnosis of various neuromuscular disorders, including motor neuron diseases, peripheral neuropathies, nerve compression syndromes, and muscle disorders. Neuromuscular diseases, such as Amyotrophic Lateral Sclerosis (ALS), Duchenne muscular dystrophy, and limb-girdle muscular dystrophy, are chronic conditions that require regular monitoring. The prevalence of these disorders ranges from 1 to 10 cases per 100,000 population. The incidence of spinal muscular atrophy is higher, affecting 4 out of every 50,000 individuals. Electromyography helps diagnose these conditions by recording the electrical activity of muscles in response to electrical stimulation using a needle electrode and a recording device. Preparation for the test may include avoiding blood thinner medication and fasting. During the test, the patient may experience pain and discomfort due to the insertion of the needle electrode.

Other diagnostic tests, such as imaging tests, blood tests, and muscle biopsies, may also be used in conjunction with EMG to provide a comprehensive diagnosis. Electromyography is essential for diagnosing conditions such as nerve compression syndromes, including carpal tunnel syndrome, pinched nerves, cervical radiculopathy, and sciatica. It is also used to diagnose muscle disorders, such as myopathies, polymyositis, dermatomyositis, post-polio syndrome, and myasthenia gravis. Electrical medical devices, such as pacemakers, may interfere with EMG results, and patients are advised to inform their healthcare provider of any electrical medical devices they use. Thus, such factors are driving the market's growth during the forecast period.

Electromyography (EMG) Devices Market Trends

Increasing use of prosthesis is the key trend in the market. Electromyography (EMG) devices are essential diagnostic tools used to assess the electrical activity of skeletal muscles and nerves. These diagnostic tests play a crucial role in identifying various muscle and nerve disorders, including motor neuron diseases, peripheral neuropathies, nerve compression syndromes, and muscle disorders such as myopathies, muscular dystrophy, polymyositis, and dermatomyositis. EMG testing involves the use of a needle electrode to record electrical signals from the muscle during muscle contraction in response to electrical stimulation. Preparation for the test may include avoiding blood thinner medication and other medications that can affect electrical activity. During EMG testing, a recording device captures the electrical signals produced by muscle contractions. These signals are then analyzed to diagnose conditions such as muscle weakness, numbness, tingling, and pain.

Further, common conditions diagnosed through EMG include nerve compression syndromes like carpal tunnel syndrome, pinched nerves, cervical radiculopathy, and sciatica. Imaging tests, blood tests, and muscle biopsies may also be used in conjunction with EMG to provide a comprehensive diagnosis. EMG devices are essential for evaluating the electrical activity of motor nerves and muscles, providing valuable information for the diagnosis and treatment of various neurological conditions. The test duration is typically short, and although it may cause some pain and discomfort, the procedure is generally well-tolerated. Electrical medical devices such as pacemakers and implantable electrodes are also being used to enhance the efficiency and accuracy of EMG testing and prosthesis movement in individuals with neurological conditions. Thus, such trends will shape the market's growth during the forecast period.

Electromyography (EMG) Devices Market Challenge

Limitations of EMG devices are the major challenge that affects the growth of the market. Electromyography (EMG) devices are essential diagnostic tools used to assess the electrical activity of skeletal muscles and nerves. This non-invasive electrodagnostic testing plays a crucial role in identifying various neuromuscular disorders, including muscle weakness, numbness, tingling, peripheral neuropathy, nerve compression syndromes such as carpal tunnel syndrome, nerve roots compression like cervical radiculopathy, and sciatica. EMG devices help evaluate motor nerves and muscle disorders, including myopathies like muscular dystrophy, polymyositis, and dermatomyositis, motor neurons disorders like post-polio syndrome, and myasthenia gravis. Preparation for EMG includes avoiding blood thinner medication and ensuring proper shaving and cleaning of the skin. The procedure involves inserting a needle electrode into the muscle and recording the electrical activity using a recording device. Electrical stimulation is also applied to elicit muscle contraction.

However, several factors impact signal detection, such as the structure of the electrode, its distance from the muscle under investigation, and the presence of noise from intermediate muscles and EKG signals. These factors can make detecting signals from the muscle of interest challenging, especially when the muscles are located deep under the skin. Imaging tests, blood tests, and muscle biopsies are often used in conjunction with EMG for a comprehensive diagnosis. Despite these challenges, EMG remains an essential tool for diagnosing and managing various neuromuscular disorders, providing valuable insights into the electrical activity of muscles and nerves. Hence, the above factors will impede the market's growth during the forecast period.

Exclusive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Allengers Medical Systems Ltd. - The company offers electromyography devices that includes neuropod electroencephalograph, Virgo electroencephalograph machine, Scorpio electromyograph machine which is used for measures muscle response or electrical activity in response to a nerve's stimulation of the muscle.

The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Ambu AS
• American Association of Neuromuscular and Electrodiagnostic Medic
• Biometrics Ltd
• BioRESEARCH Associates Inc.
• Bittium Corp.
• BTS Bioengineering Corp.
• Cadwell Industries Inc.
• Clarity Medical Pvt. Ltd
• Compumedics Ltd.
• Contec Medical Systems Co. Ltd.
• DEYMED Diagnostic sro
• Dragerwerk AG and Co. KGaA
• EMS Handels Gesellschaft mbH
• Magstim EGI
• Medtronic Plc
• Natus Medical Inc.
• NCC Medical
• Nihon Kohden Corp.
• Noraxon USA Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Analyst Overview

Electromyography (EMG) devices are essential diagnostic tools used to assess the electrical activity of skeletal muscles and nerves. These diagnostic tests play a crucial role in identifying various conditions affecting the central and peripheral nervous systems, including motor nerves, nerve roots, and peripheral nerves. EMG testing helps diagnose muscle weakness, numbness, tingling, and other symptoms associated with peripheral neuropathy, nerve compression syndromes such as carpal tunnel syndrome, and motor neuron disorders like post-polio syndrome, myasthenia gravis, and motor neuron diseases like amyotrophic lateral sclerosis. During an EMG test, a needle electrode is inserted into the muscle to record the electrical signals produced during muscle contraction. Preparation for the test may include avoiding blood thinner medication and electrical medical devices like pacemakers. The recording device measures the muscle's electrical activity, providing valuable information about muscle disorders, myopathies, and dystrophies like muscular dystrophy, polymyositis, and dermatomyositis. EMG tests complement other diagnostic methods, such as imaging tests, blood tests, and muscle biopsies, to provide a comprehensive diagnosis for patients experiencing pain and discomfort.

Download PDF Sample

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market  and its contribution of the market in focus to the parent market
• Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements.

Get in touch